1. Establishment of native insulin-negative NOD mice and the methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene.
- Author
-
Nakayama M, Moriyama H, Abiru N, Babu SR, Sikora K, Li M, Miao D, Hutton JC, Elliott JF, and Eisenbarth GS
- Subjects
- Amino Acid Substitution, Animals, Crosses, Genetic, Female, Heterozygote, Homozygote, Male, Mice, Mice, Inbred NOD, Mice, Knockout, Mice, Transgenic, Microinjections, Ovum physiology, Promoter Regions, Genetic, Alanine metabolism, Genotype, Insulin genetics, Proinsulin genetics, Protein Precursors genetics, Transgenes
- Abstract
We hypothesize that NOD mice without native insulin, but with an altered insulin B:9-23 sequence, will be completely protected from diabetes/insulitis if insulin B:9-23 is an essential T cell epitope. To investigate this hypothesis, we have established initial insulin 1- and 2-negative NOD mice with a transgene directing production of preproinsulin with alanine at position B:16 rather than the native tyrosine of both insulin 1 and insulin 2. Sets of primers for PCR-based assays have been created and validated. They are able to distinguish the presence or absence of the insulin gene knockouts and of both native insulin 1 and insulin 2 (and thus distinguish heterozygous versus homozygous knockouts), as well as the presence of the altered insulin transgene, B:16 alanine preproinsulin. Four B:16 alanine transgenic founders were produced directly in NOD mice and, by intercrossing, initial live native insulin-negative B:16 alanine transgenic mice have been generated.
- Published
- 2004
- Full Text
- View/download PDF